The new soft capsule formulation of ritonavir
(Norvir™) has passed through the first stage of the European Union licensing
procedure after the Committee for Proprietary Medicinal Products (CPMP) adopted
a positive opinion on its approval last week. The European Commission are
expected to 'rubber stamp' this decision by mid-November, allowing the
prescription of ritonavir capsules throughout the UK and other member
states.
Until then, manufacturers Abbott Labs are making the new capsules
widely available through a named patient programme. For more details of this
scheme, doctors should contact Abbott on 01628 644370.
For further
href="http://www.aidsmap.com/article.asp?articleID=361&heading3=Ritonavir+%2D+overview">ritonavir
.